chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Productive cough, Respiratory tract congestion, Sleep disorder
Clinical narrative: I received the 1st dose of Moderna on 03/18/2021 012A21A, and a half dollar sized rash on the injection site. It was itching severely. I had to use ice pack, It was like poison ivy. Hydrocortisone cream helped it go away. On my 2nd dose about three days later I would wake up in the middle of night with congestion cough, and shortness of breath. This only occurred in the middle of the night. I called my doctor, because the cough was extreme with phlegm. My PCP had me do a rescue albuterol inhaler and had me use it with a canister. I used this for almost a month in a half a couple of times a week at night. I received my booster dose on 12/28/2021 LOT#013F21A. It was a week after and the same symptoms came back, but it wasn't as bad as the 2nd dose. I'm still waking up in the middle of the night with shortness of breath, I cough a little and I haven't used the inhaler going on at least two months. The third dose was nothing like the second dose. I am also concerned about my blood pressure, it has always been normal, but my blood work has shown that my cholesterol has went up about 20 points. I have noticed also there are days when I'm short of breath and I do not have the stamina as I used to. I feel weak on some days.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antiphospholipid antibodies, Blood culture, C-reactive protein, COVID-19 pneumonia, Full blood count
Clinical narrative: Patient hospitalized for COVID-19 pneumonia after COVID-19 vaccination. Received remdesivir and steroids and discharged to home medically stable.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lipids, Liver function test, Metabolic function test
Clinical narrative: Patient hospitalized for COVID-19 pneumonia after COVID-19 vaccination. Received remdesivir and steroids and discharged to home medically stable.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Pain
Clinical narrative: Patient developed chest discomfort the day after receiving her COVID booster. She describes it as midsternal, occasionally radiates to the left of the sternum, has been rather constant dull achy pain at baseline, occasionally gets worse but without any trigger with exertion, eating, position, or anything really in general.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: The vaccine given had an expiration date of 3/18/22.  A stability study with Moderna is pending.  The patient reports no adverse events with this booster.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal X-ray, Abdominal distension, Anticoagulant therapy, Atelectasis, Blood fibrinogen increased
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, Cardiac dysfunction, Cardiogenic shock, Chest X-ray abnormal
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Coagulation test, Coagulopathy, Diarrhoea, Echocardiogram abnormal, Endotracheal intubation
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Flatulence, Gastric occult blood positive, Haematochezia, Haemoglobin
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Hypervolaemia, Hypophagia, Hypotension, Ileus
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Immunoglobulin therapy, Inflammatory marker increased, Intensive care, Laboratory test abnormal, Leukocytosis
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Mallory-Weiss syndrome, Multisystem inflammatory syndrome in children, Oedema peripheral, Pain, Pneumonia
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Polyuria, Pulmonary oedema, Pyrexia, Serum ferritin increased, Shift to the left
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia, Troponin increased, Urine output decreased, Ventricular dysfunction, Vomiting
Clinical narrative: 7 year old male with no significant past medical history who was admitted for tachycardia in the setting of 7 days of fevers, bloody stools (gross blood seen 1/25), NBNB vomiting, and decreased PO intake and urine output. S/p both doses of his COVID vaccine, second dose at end of December 2021. A CAT was called 1/29 due to decreased urine output, low BPs in the 80s systolic and HR persistently 120s-140s despite pain management. He received a total of 4 NS boluses over his first 2 hospital days and CXR was obtained with atelectasis vs L sided PNA. POC US done by PICU fellow showed mild-mod cardiac dysfunction. Labs were notable for increased troponin and markedly increased BNP, leukocytosis with left shift, and persistently elevated inflammatory markers. He was subsequently transferred to the PICU.  On arrival to the PICU, patient was hypotensive with fluid overload clinically (peripheral edema, pulmonary edema on CXR), consistent with cardiogenic shock. Epinephrine was started and milrinone added given ECHO with diminished biventricular function. Epi was discontinued 1/30 and milrinone continued. Nicardipine was added for afterload reduction and lovenox added given poor cardiac function. Lasix gtt was started 1/30 for diuresis, and diuril added 1/31 (though discontinued 2/1 due to adequate diuresis). Given continued hypertension, nicardipine drip was d/c'ed as amlodipine was started.  For treatment of MISC, patient received IVIG on 1/30, pulse dose steroids on 2/1 and 2/2, and continued on BID steroids with wean plan outlined by rheumatology. His inflammatory markers down-trended appropriately and his cardiac function normalized on ECHO 2/2. Given patient age and anxiety with medical therapies, he was intubated 1/30-2/3. Dex and midaz drips were started for sedation and anxiolysis. Patient remained stable on RA. Given fevers and retrocardiac opacity on CXR 1/30, patient completed 5 days of CTX for pneumonia.  Patient  developed worsening abdominal distension and emesis, requiring intermittent pauses in feeds. Abdominal xray showed ileus with significant gaseous distention. Feeds were paused 2/3 for extubation, briefly resumed, then paused again in the setting of multiple episodes of emesis (one heme occult positive emesis likely due to coagulopathy + mallory weiss tear). Distension improved with NPO/sump suctioning, and patient was able to tolerate clear liquids and meds starting 2/4. Bowel regimen was continued with small, non-bloody stool output. Patient had no further episodes of bloody stool or emesis. Hgb and coags were trended and improved. Anti-xa remained within goal while on lovenox. At the time of transfer patient was tolerating a regular diet and off all IV medications. Patient's bowel regimen was held in the setting of loose stools. Patient continued to tolerate PO and was meeting maintenance goals at the time of discharge.   Patient hospitalized from 1/28/22 to 2/8/22 with 7 days spent in ICU.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID +
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Dry skin, Dyspnoea, Insomnia, Rash, SARS-CoV-2 test negative
Clinical narrative: So the skin rash occurred gradually since Sept of 2021 and it ended up making my hand completely dry and I went to the Dr. and got the cream to get the reaction down I have used cream for some time but it did not conclude the rash and I received the cortisone shot and it went away for 3 weeks and in February I started having problems sleeping and problems breathing and I did not have the flu and tested negative for Covid. I still have the rash and it doesn't appear to be going away any time, it is only on my four fingers, and hand and in-between my fingers but it is not on my thumb. My hand also bleeds from it. The breathing and sleeping problems have resolved. I feel short but I have to take airplanes when I fly and after when I fly.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Skin haemorrhage
Clinical narrative: So the skin rash occurred gradually since Sept of 2021 and it ended up making my hand completely dry and I went to the Dr. and got the cream to get the reaction down I have used cream for some time but it did not conclude the rash and I received the cortisone shot and it went away for 3 weeks and in February I started having problems sleeping and problems breathing and I did not have the flu and tested negative for Covid. I still have the rash and it doesn't appear to be going away any time, it is only on my four fingers, and hand and in-between my fingers but it is not on my thumb. My hand also bleeds from it. The breathing and sleeping problems have resolved. I feel short but I have to take airplanes when I fly and after when I fly.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injected limb mobility decreased, Miliaria, Pain, Rash
Clinical narrative: She got her vaccine, a young girl was there, she gave her the dose really fast.  When she did it she could tell that she gave it high on her arm as she felt it. The one prior she hardly felt it at all.  Within 24 hours she could not raise her left arm at all. Within 2-3 days she could not move it and she had a severe rash of heat under her arm.  She Googled the AE and it could be an injury caused Sirva, where it can lock up the shoulder muscle where the injection site was given incorrectly at.  She tried PT at home that she saw online and within 7 days she could move it.  She went to see her PCP and told her what she felt, and he said that he had never heard of the Sirva injury and he also gave her some PT to do and examined her arm and told her she did not have as much strength in that shoulder as she did in the other.  Over time her shoulder gets better, but she still cannot raise it without severe pain.  She has flare ups at times, and it will sometimes run under her arm, almost like she has a pain in her left chest area.  Over times if she continues to lift it and do as much PT as possible it will free the arm up. She is concerned over time what kind of problems is she going to have down the road with her arm from the vaccine.  She had been laid off of work at that time and drawing her unemployment benefits and was not called back to work and is out of work, and still out of work.  She now is going to be limited to what she can lift due to the pain she has in the arm.  She does not know if it's triggered going into a sac that is causing the flare ups of pain or what it can cause.  As of yesterday she is trying to read a little bit and finding out what can happen.  Her PCP told her if she had any more issues by her next visit then maybe they should do an X-ray or further testing. The pain is not in the top of her shoulder but in the side where the arm runs.  Ibuprofen does not alleviate the pain.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Peripheral swelling, Rash
Clinical narrative: Approximately 2 days after my 2nd dose vaccination, I experienced the following symptoms: Arm swelling, Rash spreading in the injection site and spreaded toward the back of my arm and to my bicep. I did not take anything for treatment until I saw my doctor and was prescribed with an antibiotic. It helped with the rash and my symptoms subsided.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood culture negative, COVID-19, Chest X-ray normal, Cough, Culture urine positive
Clinical narrative: Patient with 1 Moderna and 1 Pfizer COVID vaccination and COVID infection back on 11/30/21 who admitted with COVID detected test and positive for cough and fever.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Covid positive Urine cx positive for E coli Hospital Course:  This 83-year-old female with a past medical history of rheumatoid arthritis, lymphocytic colitis, hypertension, who comes in comes in with 1 week of flu-like symptoms with body aches, fatigue, rhinorrhea, dry cough, change in taste.  She has some chronic frequent urination.  In the emergency room  she had fever, tachycardia, tachypnea, suggestive of sepsis.  she tested positive for COVID, urinalysis was abnormal suggestive of urinary tract infection.  She was admitted, started on Rocephin empirically.  She was not hypoxic, chest x-ray without infiltrates, did not require treatment for COVID.  Her COVID infection is minimally symptomatic with dry cough only.  Blood cultures were negative, urine cultures grew E coli, sensitive to cephalosporins.  She feels stronger, she worked with therapy.  She was transitioned to Keflex orally for urinary tract infection.  She is being discharged in stable condition to home with home health care with nursing, PT and OT. She had been admitted for COVID in December 2021, post negative in the meantime.  She received 2 doses of COVID vaccine."
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Escherichia test positive, Fatigue, Influenza like illness, Pain, Pollakiuria
Clinical narrative: Patient with 1 Moderna and 1 Pfizer COVID vaccination and COVID infection back on 11/30/21 who admitted with COVID detected test and positive for cough and fever.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Covid positive Urine cx positive for E coli Hospital Course:  This 83-year-old female with a past medical history of rheumatoid arthritis, lymphocytic colitis, hypertension, who comes in comes in with 1 week of flu-like symptoms with body aches, fatigue, rhinorrhea, dry cough, change in taste.  She has some chronic frequent urination.  In the emergency room  she had fever, tachycardia, tachypnea, suggestive of sepsis.  she tested positive for COVID, urinalysis was abnormal suggestive of urinary tract infection.  She was admitted, started on Rocephin empirically.  She was not hypoxic, chest x-ray without infiltrates, did not require treatment for COVID.  Her COVID infection is minimally symptomatic with dry cough only.  Blood cultures were negative, urine cultures grew E coli, sensitive to cephalosporins.  She feels stronger, she worked with therapy.  She was transitioned to Keflex orally for urinary tract infection.  She is being discharged in stable condition to home with home health care with nursing, PT and OT. She had been admitted for COVID in December 2021, post negative in the meantime.  She received 2 doses of COVID vaccine."
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Sepsis, Tachycardia
Clinical narrative: Patient with 1 Moderna and 1 Pfizer COVID vaccination and COVID infection back on 11/30/21 who admitted with COVID detected test and positive for cough and fever.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Covid positive Urine cx positive for E coli Hospital Course:  This 83-year-old female with a past medical history of rheumatoid arthritis, lymphocytic colitis, hypertension, who comes in comes in with 1 week of flu-like symptoms with body aches, fatigue, rhinorrhea, dry cough, change in taste.  She has some chronic frequent urination.  In the emergency room  she had fever, tachycardia, tachypnea, suggestive of sepsis.  she tested positive for COVID, urinalysis was abnormal suggestive of urinary tract infection.  She was admitted, started on Rocephin empirically.  She was not hypoxic, chest x-ray without infiltrates, did not require treatment for COVID.  Her COVID infection is minimally symptomatic with dry cough only.  Blood cultures were negative, urine cultures grew E coli, sensitive to cephalosporins.  She feels stronger, she worked with therapy.  She was transitioned to Keflex orally for urinary tract infection.  She is being discharged in stable condition to home with home health care with nursing, PT and OT. She had been admitted for COVID in December 2021, post negative in the meantime.  She received 2 doses of COVID vaccine."
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachypnoea, Taste disorder, Urinary tract infection, Urine analysis abnormal
Clinical narrative: Patient with 1 Moderna and 1 Pfizer COVID vaccination and COVID infection back on 11/30/21 who admitted with COVID detected test and positive for cough and fever.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Covid positive Urine cx positive for E coli Hospital Course:  This 83-year-old female with a past medical history of rheumatoid arthritis, lymphocytic colitis, hypertension, who comes in comes in with 1 week of flu-like symptoms with body aches, fatigue, rhinorrhea, dry cough, change in taste.  She has some chronic frequent urination.  In the emergency room  she had fever, tachycardia, tachypnea, suggestive of sepsis.  she tested positive for COVID, urinalysis was abnormal suggestive of urinary tract infection.  She was admitted, started on Rocephin empirically.  She was not hypoxic, chest x-ray without infiltrates, did not require treatment for COVID.  Her COVID infection is minimally symptomatic with dry cough only.  Blood cultures were negative, urine cultures grew E coli, sensitive to cephalosporins.  She feels stronger, she worked with therapy.  She was transitioned to Keflex orally for urinary tract infection.  She is being discharged in stable condition to home with home health care with nursing, PT and OT. She had been admitted for COVID in December 2021, post negative in the meantime.  She received 2 doses of COVID vaccine."
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint Pain
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal loss of weight, Bradykinesia, Carpal tunnel syndrome, Gait disturbance, Impaired work ability
Clinical narrative: 2nd dose was similar as 1st afterwards, but on 03/22/21 my quadricep muscles were paralyzed and I had to drag my feet and I couldn't lift my legs. I went to my chiropractor because I have back issues and she did a thorough check and said it has nothing to do with my back and to see my Doctor. I saw my Doctor 2 days later and she sent me for an MRI of brain and spine and did labs and everything came back negative. I didn't know what to do and no one could diagnose what was wrong. I dealt with the basic paralysis for about a week and kept walking as much as I could and tried to be as active as much as I could. A week later I was able to walk normally. I missed two weeks of work and I couldn't function and I was slow. Since that and within that time and November, I had a 10 pound weight loss with no effort to lose weight, and the interesting thing is I had been lifting weights and exercising and with doing that I lost muscle and it was visible and noticeable and very rapid. I've had difficulty ever since with maintaining my weight and the Doctor said I was underweight and I can't gain any fat or muscle weight of any substance. It was very unusual circumstances for me and it was profound and immediately after leg issues. I've been evaluated for MS and have had my spine looked at with MRI and everything came back negative. My neurologist said my Vitamin D was low so I've been taking that and my labs are back to normal. I can function normally and muscles seem to be working but I've been having issues with maintaining weight and muscle even with dietary changes. I've had a nerve conduction test of my whole body done and Doctor said I have carpal tunnel but no leg problems, but I'll go see him again and have more testing.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Laboratory test normal, Loss of personal independence in daily activities, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal
Clinical narrative: 2nd dose was similar as 1st afterwards, but on 03/22/21 my quadricep muscles were paralyzed and I had to drag my feet and I couldn't lift my legs. I went to my chiropractor because I have back issues and she did a thorough check and said it has nothing to do with my back and to see my Doctor. I saw my Doctor 2 days later and she sent me for an MRI of brain and spine and did labs and everything came back negative. I didn't know what to do and no one could diagnose what was wrong. I dealt with the basic paralysis for about a week and kept walking as much as I could and tried to be as active as much as I could. A week later I was able to walk normally. I missed two weeks of work and I couldn't function and I was slow. Since that and within that time and November, I had a 10 pound weight loss with no effort to lose weight, and the interesting thing is I had been lifting weights and exercising and with doing that I lost muscle and it was visible and noticeable and very rapid. I've had difficulty ever since with maintaining my weight and the Doctor said I was underweight and I can't gain any fat or muscle weight of any substance. It was very unusual circumstances for me and it was profound and immediately after leg issues. I've been evaluated for MS and have had my spine looked at with MRI and everything came back negative. My neurologist said my Vitamin D was low so I've been taking that and my labs are back to normal. I can function normally and muscles seem to be working but I've been having issues with maintaining weight and muscle even with dietary changes. I've had a nerve conduction test of my whole body done and Doctor said I have carpal tunnel but no leg problems, but I'll go see him again and have more testing.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle atrophy, Musculoskeletal disorder, Nerve conduction studies normal, Paralysis, Similar reaction on previous exposure to drug
Clinical narrative: 2nd dose was similar as 1st afterwards, but on 03/22/21 my quadricep muscles were paralyzed and I had to drag my feet and I couldn't lift my legs. I went to my chiropractor because I have back issues and she did a thorough check and said it has nothing to do with my back and to see my Doctor. I saw my Doctor 2 days later and she sent me for an MRI of brain and spine and did labs and everything came back negative. I didn't know what to do and no one could diagnose what was wrong. I dealt with the basic paralysis for about a week and kept walking as much as I could and tried to be as active as much as I could. A week later I was able to walk normally. I missed two weeks of work and I couldn't function and I was slow. Since that and within that time and November, I had a 10 pound weight loss with no effort to lose weight, and the interesting thing is I had been lifting weights and exercising and with doing that I lost muscle and it was visible and noticeable and very rapid. I've had difficulty ever since with maintaining my weight and the Doctor said I was underweight and I can't gain any fat or muscle weight of any substance. It was very unusual circumstances for me and it was profound and immediately after leg issues. I've been evaluated for MS and have had my spine looked at with MRI and everything came back negative. My neurologist said my Vitamin D was low so I've been taking that and my labs are back to normal. I can function normally and muscles seem to be working but I've been having issues with maintaining weight and muscle even with dietary changes. I've had a nerve conduction test of my whole body done and Doctor said I have carpal tunnel but no leg problems, but I'll go see him again and have more testing.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Underweight, Vitamin D decreased
Clinical narrative: 2nd dose was similar as 1st afterwards, but on 03/22/21 my quadricep muscles were paralyzed and I had to drag my feet and I couldn't lift my legs. I went to my chiropractor because I have back issues and she did a thorough check and said it has nothing to do with my back and to see my Doctor. I saw my Doctor 2 days later and she sent me for an MRI of brain and spine and did labs and everything came back negative. I didn't know what to do and no one could diagnose what was wrong. I dealt with the basic paralysis for about a week and kept walking as much as I could and tried to be as active as much as I could. A week later I was able to walk normally. I missed two weeks of work and I couldn't function and I was slow. Since that and within that time and November, I had a 10 pound weight loss with no effort to lose weight, and the interesting thing is I had been lifting weights and exercising and with doing that I lost muscle and it was visible and noticeable and very rapid. I've had difficulty ever since with maintaining my weight and the Doctor said I was underweight and I can't gain any fat or muscle weight of any substance. It was very unusual circumstances for me and it was profound and immediately after leg issues. I've been evaluated for MS and have had my spine looked at with MRI and everything came back negative. My neurologist said my Vitamin D was low so I've been taking that and my labs are back to normal. I can function normally and muscles seem to be working but I've been having issues with maintaining weight and muscle even with dietary changes. I've had a nerve conduction test of my whole body done and Doctor said I have carpal tunnel but no leg problems, but I'll go see him again and have more testing.